EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Cannabinoids in Integumentary Wound Care: A Systematic Review of Emerging Preclinical and Clinical Evidence

Dhakshila Niyangoda iD, Mohammed Muayad, Wubshet Tesfaye iD, Mary Bushell iD, Danish Ahmad, Indira Samarawickrema, Justin Sinclair, Shida Kebriti, Vincent Maida, Jackson Thomas

Pharmaceutics · 17.08.2024 · 16 (8) · 1081

DOI: 10.3390/pharmaceutics16081081 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 17.08.2024. Verfasst von Dhakshila Niyangoda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health, University of Canberra, Canberra, ACT 2617, Australia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 264 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Accelerating Higher Education Expansion and Development Operation (AHEAD), Sri Lanka (AHEAD/PhD/R3/AH/369), University of Canberra, Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This systematic review critically evaluates preclinical and clinical data on the antibacterial and wound healing properties of cannabinoids in integument wounds. Comprehensive searches were conducted across multiple databases, including CINAHL, Cochrane library, Medline, Embase, PubMed, Web of Science, and LILACS, encompassing records up to May 22, 2024. Eighteen studies met the inclusion criteria. Eleven were animal studies, predominantly utilizing murine models (n = 10) and one equine model, involving 437 animals. The seven human studies ranged from case reports to randomized controlled trials, encompassing 92 participants aged six months to ninety years, with sample sizes varying from 1 to 69 patients. The studies examined the effects of various cannabinoid formulations, including combinations with other plant extracts, crude extracts, and purified and synthetic cannabis-based medications administered topically, intraperitoneally, orally, or sublingually. Four animal and three human studies reported complete wound closure. Hemp fruit oil extract, cannabidiol (CBD), and GP1a resulted in complete wound closure in twenty-three (range: 5–84) days with a healing rate of 66–86% within ten days in animal studies. One human study documented a wound healing rate of 3.3 cm2 over 30 days, while three studies on chronic, non-healing wounds reported an average healing time of 54 (21–150) days for 17 patients by oral oils with tetrahydrocannabinol (THC) and CBD and topical gels with THC, CBD, and terpenes. CBD and tetrahydrocannabidiol demonstrated significant potential in reducing bacterial loads in murine models. However, further high-quality research is imperative to fully elucidate the therapeutic potential of cannabinoids in the treatment of bacterial skin infections and wounds. Additionally, it is crucial to delineate the impact of medicinal cannabis on the various phases of wound healing. This study was registered in PROSPERO (CRD42021255413).

Schlagwörter

Stichwörter der Autor:innen

antibacterialantimicrobial resistancecannabinoidsmedicinal cannabiswound healing

Autor:innen und Institutionen

  • Faculty of Health, University of Canberra, Canberra, ACT 2617, Australia.
  • Department of Pharmacy, Faculty of Allied Health Sciences, University of Peradeniya, Peradeniya 20400, Sri Lanka.
  • School of Pharmacy, Faculty of Health and Behavioural Sciences, University of Queensland, Queensland, QLD 4072, Australia.
  • School of Medicine and Psychology, Australian National University, Canberra, ACT 2601, Australia.
  • Strategy Coaching and Research Consulting Pty Ltd., O'Malley, ACT 2606, Australia.
  • Australian Natural Therapeutics Group, Byron Bay, NSW 2481, Australia.

ORCID-Profile: Dhakshila Niyangoda, Wubshet Tesfaye, Mary Bushell

Förderung

  • Accelerating Higher Education Expansion and Development Operation (AHEAD), Sri Lanka (AHEAD/PhD/R3/AH/369)
  • University of Canberra, Australia

Zitieren

APA

Niyangoda, D., Muayad, M., Tesfaye, W., Bushell, M., Ahmad, D., Samarawickrema, I., Sinclair, J., Kebriti, S., Maida, V., & Thomas, J. (2024). Cannabinoids in Integumentary Wound Care: A Systematic Review of Emerging Preclinical and Clinical Evidence. Pharmaceutics, 16(8), 1081. https://doi.org/10.3390/pharmaceutics16081081

Vancouver

Niyangoda D, Muayad M, Tesfaye W, Bushell M, Ahmad D, Samarawickrema I, et al. Cannabinoids in Integumentary Wound Care: A Systematic Review of Emerging Preclinical and Clinical Evidence. Pharmaceutics. 2024;16(8):1081. doi:10.3390/pharmaceutics16081081

BibTeX
@article{Niyangoda2024,
  author = {Niyangoda, Dhakshila and Muayad, Mohammed and Tesfaye, Wubshet and Bushell, Mary and Ahmad, Danish and Samarawickrema, Indira and Sinclair, Justin and Kebriti, Shida and Maida, Vincent and Thomas, Jackson},
  title = {Cannabinoids in Integumentary Wound Care: A Systematic Review of Emerging Preclinical and Clinical Evidence},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {8},
  pages = {1081},
  doi = {10.3390/pharmaceutics16081081}
}
Kostenlos starten →